Imugene Limited (ASX:IMU)
Australia
· Delayed Price · Currency is AUD 0.4760
+0.0340 (7.69%)
Jul 3, 2025, 4:43 AM AEST
Imugene Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Other Revenue | -1.84 | 4.97 | 11.78 | 12.97 | 7.23 | 4.13 | Upgrade
|
| -1.84 | 4.97 | 11.78 | 12.97 | 7.23 | 4.13 | Upgrade
| |
Revenue Growth (YoY) | - | -57.80% | -9.19% | 79.35% | 74.94% | 0.16% | Upgrade
|
Gross Profit | -1.84 | 4.97 | 11.78 | 12.97 | 7.23 | 4.13 | Upgrade
|
Selling, General & Admin | 44.37 | 59.91 | 20.43 | 14.06 | 10.31 | 5.52 | Upgrade
|
Research & Development | 73.51 | 86.89 | 30.86 | 36.61 | 15.36 | 9.36 | Upgrade
|
Operating Expenses | 118.8 | 146.79 | 51.29 | 50.67 | 25.67 | 14.88 | Upgrade
|
Operating Income | -120.64 | -141.82 | -39.52 | -37.7 | -18.43 | -10.75 | Upgrade
|
Interest Expense | -0.3 | -0.48 | -0.03 | -0.01 | -0.01 | -0.01 | Upgrade
|
Interest & Investment Income | 3.53 | 4.52 | 1.88 | 0.19 | 0.13 | 0.3 | Upgrade
|
Currency Exchange Gain (Loss) | -0.63 | -0.63 | -0.25 | -0.13 | -0.08 | -0.14 | Upgrade
|
Other Non Operating Income (Expenses) | - | - | - | -0.11 | -0.11 | - | Upgrade
|
EBT Excluding Unusual Items | -118.04 | -138.42 | -37.91 | -37.76 | -18.51 | -10.58 | Upgrade
|
Gain (Loss) on Sale of Assets | -11.26 | -11.26 | -0 | -0.1 | - | - | Upgrade
|
Other Unusual Items | - | - | - | - | 0.05 | 0.08 | Upgrade
|
Pretax Income | -129.3 | -149.68 | -37.91 | -37.87 | -18.46 | -10.51 | Upgrade
|
Net Income | -129.3 | -149.68 | -37.91 | -37.87 | -18.46 | -10.51 | Upgrade
|
Net Income to Common | -129.3 | -149.68 | -37.91 | -37.87 | -18.46 | -10.51 | Upgrade
|
Shares Outstanding (Basic) | 7,352 | 7,089 | 6,276 | 5,637 | 4,664 | 4,075 | Upgrade
|
Shares Outstanding (Diluted) | 7,352 | 7,089 | 6,276 | 5,637 | 4,664 | 4,075 | Upgrade
|
Shares Change (YoY) | 10.54% | 12.96% | 11.33% | 20.88% | 14.45% | 13.76% | Upgrade
|
EPS (Basic) | -0.02 | -0.02 | -0.01 | -0.01 | -0.00 | -0.00 | Upgrade
|
EPS (Diluted) | -0.02 | -0.02 | -0.01 | -0.01 | -0.00 | -0.00 | Upgrade
|
Free Cash Flow | -102.04 | -108.8 | -31.47 | -31.11 | -13.42 | -10.44 | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | Upgrade
|
Gross Margin | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
Operating Margin | - | -2853.55% | -335.51% | -290.70% | -254.92% | -259.94% | Upgrade
|
Profit Margin | - | -3011.66% | -321.92% | -291.98% | -255.21% | -254.19% | Upgrade
|
Free Cash Flow Margin | - | -2189.12% | -267.21% | -239.83% | -185.53% | -252.62% | Upgrade
|
EBITDA | -116.82 | -137.45 | -37.31 | -35.45 | -16.55 | -10.72 | Upgrade
|
EBITDA Margin | - | - | - | -273.30% | -228.81% | -259.26% | Upgrade
|
D&A For EBITDA | 3.82 | 4.38 | 2.2 | 2.26 | 1.89 | 0.03 | Upgrade
|
EBIT | -120.64 | -141.82 | -39.52 | -37.7 | -18.43 | -10.75 | Upgrade
|
EBIT Margin | - | - | - | -290.70% | -254.92% | -259.94% | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.